Prokidney PROK
NASDAQ PROK
$1.11 -0.04 (-3.48%)
At close: Nov 10, 2026 · 4:00 PM EST

Prokidney (PROK) Shares Outstanding (Diluted) (2021 - 2026)

Updated

Prokidney's Weighted Average Shares Outstanding (Diluted) was 186.56 million in Q2 2026, up 42.7% from 130.73 million a year earlier and up 31.5% from the prior quarter.

Analysis

Prokidney (PROK) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding (Diluted) at Prokidney came in at 133.94 million, up 36.8% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has now increased for three consecutive years, with a four-year compound annual growth rate of 122.1% (FY2021 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding (Diluted) was 97.92 million in FY2024 (+58.7%), 61.71 million in FY2023 (+0.3%), 61.54 million in FY2022 and 5.5 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2021.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for nine straight quarters, with growth averaging 55.5% over the last eight quarters.
  • The best year-over-year quarter for Weighted Average Shares Outstanding (Diluted) over five years was Q2 2022 (growth of 479.8%); the worst was Q1 2024 (a decline of 1.0%).
  • Per Business Quant data, PROK's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 141.93 million (Q1 2026), 133.94 million (Q4 2025) and 134.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Prokidney 567.48 Mn 1.19 Bn - 186.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 186.56 Mn
Mar 31, 2026 141.93 Mn
Dec 31, 2025 133.94 Mn
Sep 30, 2025 134.99 Mn
Jun 30, 2025 130.73 Mn
Mar 31, 2025 128.98 Mn
Dec 31, 2024 97.92 Mn
Sep 30, 2024 126.17 Mn
Jun 30, 2024 75.91 Mn
Mar 31, 2024 60.95 Mn
Dec 31, 2023 61.71 Mn
Sep 30, 2023 61.59 Mn
Jun 30, 2023 64.56 Mn
Mar 31, 2023 61.54 Mn
Dec 31, 2022 61.54 Mn
Sep 30, 2022 61.54 Mn
Jun 30, 2022 31.89 Mn
Mar 31, 2022 5.50 Mn
Dec 31, 2021 5.50 Mn
Sep 30, 2021 5.50 Mn
API Access

Prokidney Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PROK&period=max&api_key=YOUR_API_KEY